Clinical outcomes with momelotinib ivs/i ruxolitinib in patients with myelofibrosis and anemia: subgroup analysis of SIMPLIFY-1
Gupta, V Oh, S Devos, T Dubruille, V Catalano, J Somervaille, Timothy Giraldo, P Kosugi, H Sacha, T Mayer, J
Gupta, V
Oh, S
Devos, T
Dubruille, V
Catalano, J
Somervaille, Timothy
Giraldo, P
Kosugi, H
Sacha, T
Mayer, J
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Gupta V, Oh S, Devos T, Dubruille V, Catalano J, Somervaille T, et al. Clinical Outcomes With Momelotinib <i>vs</i> Ruxolitinib in Patients With Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-1. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023 SEP;23:S402-S3. PubMed PMID: WOS:001062479600389. English.